Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK vaccines minister says Pfizer supply tight but on track for target

Fri, 11th Jun 2021 11:45

(Alliance News) - UK vaccines minister Nadhim Zahawi has admitted that Pfizer Inc-BioNTech SE vaccine supplies will be "tight" over the next few weeks, but said he is still confident of offering every adult a first dose by the end of July.

It comes after Scotland's Health Secretary warned supply of the vaccine will be "particularly tight" over the next few weeks, restricting the vaccination programme's rollout.

Humza Yousaf has written to his UK government counterpart Matt Hancock to ask what can be done to increase the supply of the vaccine.

But Zahawi told LBC: "I am absolutely confident, and I'll speak to Humza on this, that we will be able to deliver the Pfizer vaccines that Scotland needs to be able to meet its targets for end of July, as the UK target."

Asked if it would be "tight" in the next few weeks, he said: "It will be, there is no doubt. Every time I've come on your show I've said that the determining factor in terms of vaccine-in-arms is supply.

"And supply remains finite, but it is stable, and Pfizer have done a great job in being consistent on their delivery schedule.

"Pfizer have done remarkable things to increase their production, not just for us but for the whole world, for Europe and the US as well. But it is tight."

He said every country has a delivery schedule, adding: "I'm confident that Scotland will be able to meet the target of offering every adult at least one dose by the end of July, as we will in England as well."

Pfizer said in a statement: "We are working relentlessly to support the rollout of Covid-19 vaccination campaigns worldwide.

"In the UK, quarter one deliveries, January to March, were completed in line with our contractual agreement and we remain on course to continue to deliver a steady supply of vaccines to the UK, in accordance with the monthly schedule, agreed in advance with the Vaccines Taskforce.

"Decisions on dosing regimens and how best to roll out the vaccination programme to priority groups sit with the health authorities in each country."

Ahead of a four-nation call on Thursday, Yousaf said Scotland needs more Pfizer-BioNTech doses if it is to "maintain or increase" the rollout.

He said he was "conscious" that a recommendation from the Joint Committee on Vaccination & Immunisation that the AstraZeneca PLC vaccine should not be used for those under 40 had placed "increased pressure" on supplies.

By Emma Bowden, PA

source: PA

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
11 Apr 2024 17:13

FTSE 100 edges lower as financials drag

Lok'nStore surges to all-time high after buyout by Shurgard

*

Read more
11 Apr 2024 17:07

Banks weigh down Europe's STOXX 600 after ECB signals rate cuts

Outlook hike sends Ambu shares up

*

Read more
11 Apr 2024 15:56

London close: Stocks finish lower as ECB stands pat

(Sharecast News) - London's stock markets finished in negative territory on Thursday, as investors reacted to the European Central Bank's latest policy announcement and a producer price index release in the United States.

Read more
11 Apr 2024 11:50

LONDON MARKET MIDDAY: Europe takes hit on nerves ahead of ECB decision

(Alliance News) - European equities sunk lower at midday on Thursday, with sentiment hurt by hotter-than-expected inflation from the US crushing hopes of interest rate cuts.

Read more
11 Apr 2024 08:56

TOP NEWS: Astra plans 7% dividend hike for 2024 after no rise in 2023

(Alliance News) - AstraZeneca PLC said it intends to raise its annualised dividend for 2024, citing confidence in its business performance and cash generation.

Read more
11 Apr 2024 08:54

LONDON MARKET OPEN: European markets mixed ahead of ECB decision

(Alliance News) - European equities lacked direction early Thursday morning, ahead of an interest rate decision from the European Central Bank this afternoon.

Read more
11 Apr 2024 07:49

LONDON BRIEFING: Astra promises dividend hike; Darktrace ups guidance

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye the latest interest rate decision from the European Central Bank, a day after a hotter-than-expected US inflation reading.

Read more
11 Apr 2024 07:20

AstraZeneca to hike 2024 dividend by 7%

(Sharecast News) - Biopharma giant AstraZeneca has announced that it will increase its annual dividend by 7%, which the board said demonstrates its confidence in the company's performance and cash generation.

Read more
8 Apr 2024 08:36

TOP NEWS: AstraZeneca hails neurological data for Ultomiris, Soliris

(Alliance News) - AstraZeneca PLC on Monday said long-term data in generalised myasthenia gravis will underscore the "vital role" of its Ultomiris and Soliris antibodies in the treatment landscape.

Read more
8 Apr 2024 07:43

LONDON BRIEFING: Astra hails neurology data; CVS flags cyberattack

(Alliance News) - London's FTSE 100 is called to open a touch higher on Monday, ahead of an interest rate decision in the eurozone and a US inflation reading later in the week.

Read more
8 Apr 2024 07:02

AstraZeneca's Enhurtu cancer gets US green light for adult patients

(Sharecast News) - AstraZeneca and Daiichi Sankyo's Enhertu cancer drug has been approved in the US for adult patients with unresectable or metastatic solid tumours who have received prior systemic treatment and have no satisfactory alternative options.

Read more
8 Apr 2024 06:53

TOP NEWS: AstraZeneca's, Daiichi's Enhertu receives US FDA approval

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Saturday announced that the US Food & Drug Administration has approved their cancer drug conjugate for patients with metastatic HER2-positive solid tumours.

Read more
5 Apr 2024 09:42

AstraZeneca makes "breakthrough" in treating small cell lung cancer

(Alliance News) - AstraZeneca PLC on Friday reported positive results relating to its Imfinzi cancer treatment in phase III trials.

Read more
5 Apr 2024 07:50

LONDON BRIEFING: Shell to book USD600 million first-quarter write-off

(Alliance News) - London's FTSE 100 is called to open lower on Friday, with hawkish remarks from Federal Reserve policymakers and fears of ratcheting Middle East tensions giving investors little to cheer about ahead of the latest US jobs data.

Read more
5 Apr 2024 07:23

AstraZeneca announces positive lung cancer treatment trial results

(Sharecast News) - AstraZeneca announced positive high-level results from a phase three trial demonstrating significant advancements in the treatment of limited-stage small cell lung cancer (LS-SCLC) on Friday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.